Login Register Cart 0
Generic placeholder image

Current Drug Discovery Technologies

Editor-in-Chief

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Molecular Modeling of Brassicaceae Derivatives for Inhibiting Lipoxygenases: A Promising Therapeutic Strategy

Author(s): Wassila Soufi*, Hocine Allali, Faïza Boukli Hacene and Saïd Ghalem

Volume 21, Issue 4, 2024

Published on: 14 December, 2023

Article ID: e011223224117 Pages: 16

DOI: 10.2174/0115701638269042231122064738

Price: $65

Open Access Journals Promotions 2
Abstract

Introduction: Inflammation plays a crucial role in the body's defense mechanisms, but uncontrolled inflammation can lead to chronic and pathological conditions. This study aimed to identify natural compounds as potential replacements for the synthetic drug Zileuton, known for its side effects.

Method: Utilizing the MOE and Molegro modeling methods, several molecules were evaluated, and three compounds, namely 1-Isothiocyanatopent-4-en-2-ol, 7-Isothiocyanatohept-1-ene, and 5- (Isothiocyanatomethyl)-1,2,3-trimethoxybenzene, exhibited superior inhibitory properties. These compounds consistently demonstrated low energy values, indicating high inhibition potency. Notably, 5-(Isothiocyanatomethyl)-1,2,3-trimethoxybenzene emerged as the most promising candidate among all tested compounds.

Results: These findings provide valuable insights for the development of alternative anti-inflammatory agents. Further research is required to assess the efficacy and safety profiles of these compounds in clinical settings.

Conclusion: This study represents a significant advancement in the search for innovative therapeutic strategies to manage inflammation-related disorders.

Keywords: Protein, isothiocyanate, inflammation, molecular modeling, ADME properties, plant extract.

Graphical Abstract

[1]
Kulkarni A, Nadler JL, Mirmira RG, Casimiro I. Regulation of tissue inflammation by 12-Lipoxygenases. Biomolecules 2021; 11(5): 717.
[http://dx.doi.org/10.3390/biom11050717] [PMID: 34064822]
[2]
Patrignani P, Steinhilber D. Editorial: Insights in inflammation pharmacology: 2021. Front Pharmacol 2022; 13: 928535.
[http://dx.doi.org/10.3389/fphar.2022.928535] [PMID: 35712698]
[3]
Benyelles B, Allali H, Touaibia M, et al. Antioxidant and anti-Inflammatory activities of the volatile components of Tropaeolum majus L. (Garden Nasturtium) from North western Algeria. J Pharm Chem Biol Sci 2016; 4(3): 431-9.
[4]
Fahey JW, Zalcmann AT, Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001; 56(1): 5-51.
[http://dx.doi.org/10.1016/S0031-9422(00)00316-2] [PMID: 11198818]
[5]
Kamal RM, Abdull Razis AF, Mohd Sukri NS, et al. Beneficial health effects of glucosinolates-derived isothiocyanates on cardiovascular and neurodegenerative Diseases. Molecules 2022; 27(3): 624.
[http://dx.doi.org/10.3390/molecules27030624] [PMID: 35163897]
[6]
Carlson HA. Protein flexibility and drug design: How to hit a moving target. Curr Opin Chem Biol 2002; 6(4): 447-52.
[http://dx.doi.org/10.1016/S1367-5931(02)00341-1] [PMID: 12133719]
[7]
Carlson H. Protein flexibility is an important component of structure-based drug discovery. Curr Pharm Des 2002; 8(17): 1571-8.
[http://dx.doi.org/10.2174/1381612023394232] [PMID: 12052201]
[8]
Teague SJ. Implications of protein flexibility for drug discovery. Nat Rev Drug Discov 2003; 2(7): 527-41.
[http://dx.doi.org/10.1038/nrd1129] [PMID: 12838268]
[9]
Abuelizz HA, Bakheit AH, Al-Agamy MH, Rashid H, Mostafa GAE, Al-Salahi R. Benzo[g]quinazolines as antifungal against candidiasis: Screening, molecular docking, and QSAR investigations. Saudi Pharm J 2023; 31(6): 815-23.
[http://dx.doi.org/10.1016/j.jsps.2023.04.012] [PMID: 37228321]
[10]
Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000; 28(1): 235-42.
[http://dx.doi.org/10.1093/nar/28.1.235] [PMID: 10592235]
[11]
Sundén H, Schäfer A, Scheepstra M, et al. Chiral dihydrobenzofuran acids show potent retinoid X receptor–nuclear receptor related 1 protein dimer activation. J Med Chem 2016; 59(3): 1232-8.
[http://dx.doi.org/10.1021/acs.jmedchem.5b01702] [PMID: 26820900]
[12]
Kankanala J, Kirby K, Liu F, et al. Design, synthesis and biological evaluations of hydroxypyridone carboxylic acids as inhibitors of HIV reverse transcriptase associated RNase H. J Med Chem 2016; 59(10): 5051-62.
[http://dx.doi.org/10.1021/acs.jmedchem.6b00465] [PMID: 27094954]
[13]
Bitencourt-Ferreira G, Filgueira de Azevedo W. Molegro virtual docker for docking. Methods Mol Biol 2019; 2053: 149-67.
[http://dx.doi.org/10.1007/978-1-4939-9752-7_10]
[14]
Molecular Operating Environment (MOE).
[15]
Temml V, Kutil Z. Structure-based molecular modeling in SAR analysis and lead optimization. Comput Struct Biotechnol J 2021; 19: 1431-44.
[http://dx.doi.org/10.1016/j.csbj.2021.02.018] [PMID: 33777339]
[16]
Goto J, Kataoka R, Muta H, Hirayama N. ASEDock-docking based on alpha spheres and excluded volumes. J Chem Inf Model 2008; 48(3): 583-90.
[http://dx.doi.org/10.1021/ci700352q] [PMID: 18278891]
[17]
Kokh DB, Amaral C, Wade RC. Perspective on protein–ligand molecular dynamics: Advances, challenges and pitfalls. J Chem Inf Model 2022; 62(4): 1427-40.
[18]
Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017; 7(1): 42717.
[http://dx.doi.org/10.1038/srep42717] [PMID: 28256516]
[19]
Ayachi H, Merad M, Ghalem S. Study of interaction between dipeptidyl peptidase-4 and products extracted from the Stevia plant by molecular modeling. Int J Pharm Sci Rev Res 2013; 23(1): 87-90.
[20]
Imberty A, Hardman KD, Carver JP, Pérez S. Molecular modelling of protein-carbohydrate interactions. Docking of monosaccharides in the binding site of concanavalin A. Glycobiology 1991; 1(6): 631-42.
[http://dx.doi.org/10.1093/glycob/1.6.631] [PMID: 1822243]
[21]
Abdelli I, Hassani F, Bekkel Brikci S, Ghalem S. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. J Biomol Struct Dyn 2020; 2020: 0739-1102.
[http://dx.doi.org/10.1080/07391102.2020.1763199]
[22]
Yamaguchi H, Akitaya T, Yu T, et al. Homology modeling and structural analysis of 11β-hydroxysteroid dehydrogenase type 2. Eur J Med Chem 2011; 46(4): 1325-30.
[http://dx.doi.org/10.1016/j.ejmech.2011.01.054] [PMID: 21333409]
[23]
Oyesakin YM, George DE, Fadare RY, Idris AY, Fadare OA. Molecular docking and In-Silico ADME prediction of substituted (E)-4-Styryl-7,8-dihydroquinazolin-5(6H)-ones and 5-((E)-Styryl)pyrimidine[4,5-d]pyrimidine-2,4(1H,3H)-diones as potential SERT inhibitors and antidepressants. Am J Pharmacol Sci 2018; 6(1): 25-32.
[http://dx.doi.org/10.12691/ajps-6-1-5]
[24]
Clark AM, Labute P, Santavy M. 2D structure depiction. J Chem Inf Model 2006; 46(3): 1107-23.
[http://dx.doi.org/10.1021/ci050550m] [PMID: 16711731]
[25]
Clark AM, Labute P. Detection and assignment of common scaffolds in project databases of lead molecules. J Med Chem 2009; 52(2): 469-83.
[http://dx.doi.org/10.1021/jm801098a] [PMID: 19093885]
[26]
Daina A, Zoete V. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 2016; 11(11): 1117-21.
[http://dx.doi.org/10.1002/cmdc.201600182] [PMID: 27218427]
[27]
Daina A, Michielin O, Zoete V. iLOGP: A simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach. J Chem Inf Model 2014; 54(12): 3284-301.
[http://dx.doi.org/10.1021/ci500467k] [PMID: 25382374]
[28]
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1. Adv Drug Deliv Rev 2001; 46(1-3): 3-26.
[http://dx.doi.org/10.1016/S0169-409X(00)00129-0] [PMID: 11259830]
[29]
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002; 45(12): 2615-23.
[http://dx.doi.org/10.1021/jm020017n] [PMID: 12036371]
[30]
Egan WJ, Merz KM Jr, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem 2000; 43(21): 3867-77.
[http://dx.doi.org/10.1021/jm000292e] [PMID: 11052792]

Rights & Permissions Print Cite
Article Metrics
23
1
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy